A conserved fungal hub protein involved in adhesion and drug resistance in the human pathogen Candida albicans by Martin-Yken, Hélène et al.
HAL Id: hal-02091662
https://hal.archives-ouvertes.fr/hal-02091662
Submitted on 4 Nov 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
A conserved fungal hub protein involved in adhesion and
drug resistance in the human pathogen Candida albicans
Hélène Martin-Yken, Tina Bedekovic, Alexandra Brand, Mathias Richard,
Sadri Znaidi, Christophe d’Enfert, Etienne Dague
To cite this version:
Hélène Martin-Yken, Tina Bedekovic, Alexandra Brand, Mathias Richard, Sadri Znaidi, et al.. A
conserved fungal hub protein involved in adhesion and drug resistance in the human pathogen Candida
albicans. The Cell Surface, Elsevier, 2018, 4, pp.10-19. ￿10.1016/j.tcsw.2018.10.002￿. ￿hal-02091662￿
1 
 
 1 
 2 
A conserved fungal hub protein involved in adhesion and drug  3 
resistance in the human pathogen Candida albicans. 4 
 5 
 6 
 7 
 8 
Hélène Martin-Yken*
1,2
,  Tina Bedekovič
3
, Alexandra Brand
3
, Mathias L. Richard
4
, Sadri 9 
Znaidi
5,6
  Christophe d'Enfert and Etienne Dague
2
. 10 
 11 
 12 
 13 
 14 
 15 
1 INSA, UPS, INP, ISAE, LAAS, Université de Toulouse, Toulouse, France; 16 
UMR792 Ingénierie des Systèmes Biologiques et des Procédés, INRA, Toulouse, 17 
France; UMR5504, CNRS, Toulouse, France. 18 
 19 
 20 
2 LAAS CNRS UPR 8001, Université de Toulouse, Toulouse, France. 21 
 22 
 23 
3 MRC Centre for Medical Mycology, School of Medicine, Medical Sciences & 24 
Nutrition, University of Aberdeen, Aberdeen, United Kingdom. 25 
 26 
 27 
4 INRA, UMR1319 Micalis, AgroParisTech, Jouy-en-Josas, France. 28 
 29 
5 Institut Pasteur de Tunis, Laboratoire de Microbiologie Moléculaire, Vaccinologie et 30 
Développement Biotechnologique, 13 Place Pasteur, Tunis-Belvédère, Tunisia  31 
 32 
6 Institut Pasteur, INRA, Unité Biologie et Pathogénicité Fongiques, 25 rue du 33 
Docteur Roux, Paris, France. 34 
 35 
 36 
*For correspondance: helene.martin@insa-toulouse.fr 37 
 38 
 39 
Declarations of interest: none. 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
2 
 
ABSTRACT 51 
 52 
 53 
Drug resistance and cellular adhesion are two key elements of the worldwide dissemination 54 
and prevalence of the human fungal pathogen Candida albicans. Smi1 belongs to a family of 55 
hub proteins conserved among the fungal kingdom, whose functions in cellular signaling 56 
affect morphogenesis, cell wall synthesis and stress resistance. The data presented here 57 
indicate that C. albicans SMI1 is a functional homolog of Saccharomyces cerevisiae KNR4 58 
and is involved in the regulation of the fungal cell wall synthesis. Expression of SMI1 in the 59 
S. cerevisiae knr4Δ null mutant rescued its sensitivity to Caspofungin and to heat stress. 60 
Deletion of SMI1 in C. albicans resulted in sensitivity to the cell-wall-perturbing compounds 61 
Calcofluor White and Caspofungin. Analysis of wild-type and mutant cells by Atomic Force 62 
Microscopy showed that the Young’s Modulus (stiffness) of the cell wall was significantly 63 
reduced upon deletion of SMI1, while cell surface adhesion measured by Single Force 64 
Spectroscopy showed that the surface expression of adhesive molecules was also reduced in 65 
the mutant. Over-expression of SMI1 gene, on the contrary, drastically increased the cell 66 
surface adhesion phenotype vs the control strain. Finally, Smi1 cellular localization as 67 
cytoplasmic patches and concentrated spots at the sites of new cell wall synthesis is consistent 68 
with its role in the control of cell wall synthesis and appears conserved with the ones of its 69 
counterparts in S. cerevisiae and Neurospora crassa respectively for yeast cells and hyphae of 70 
C. albicans. 71 
  72 
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 73 
 74 
INTRODUCTION  75 
 76 
 Fungal infections are responsible of the death of about 1.5 million people per year 77 
worldwide. Hemiascomycetous yeasts of the genus Candida are the second most numerous 78 
agents of fungal infections worldwide, with a prominent contribution by Candida albicans, 79 
which causes over 400,000 cases of life-threatening systemic infections and 200,000 deaths 80 
per year (Brown et al., 2012). Only four classes of antifungal (AF) drugs are available for 81 
patient treatment and the emergence of resistance is becoming a serious concern. The 82 
fungistatic group of Azoles and the more recently-developed fungicidal group of 83 
Echinocandins constitute the two major classes of AF used to treat patients. Azoles block the 84 
biosynthesis of ergosterol - an essential sterol for fungal cell membranes - by targeting the 85 
cytochrome P450 14-α demethylase enzyme, Erg11, which catalyzes the  conversion  of  86 
lanosterol  to  ergosterol, thereby affecting membrane integrity and inhibiting fungal growth 87 
(Kathiravan et al., 2012; Vanden Bossche et al., 1995). On the other hand, Echinocandins, a 88 
class of compounds developed between 2001 and 2006, target the catalytic sub-unit of the β-89 
1,3 glucan synthase protein complex, Fks1 (Odds et al., 2003). Studies of the molecular 90 
mechanisms of resistance to these two classes of AF compounds (recently reviewed in 91 
(Scorzoni et al., 2017)) have revealed that there are three major mechanisms leading to 92 
resistance: overexpression of multidrug efflux pump-encoding genes, notably CDR1, CDR2 93 
and MDR1 (Sanglard and Odds, 2002; Sanglard et al., 1995), point mutations in the target 94 
proteins (ex: Erg11, Fks1) and alteration in the expression of proteins involved in sensitivity 95 
to the drug (ex: Erg3, Erg11). In addition, the formation of fungal biofilms can also be 96 
considered as a form of antifungal resistance due to the ability of the biofilm extracellular 97 
matrix (ECM) to bind and entrap antifungal compounds, particularly Azoles and 98 
Amphotericin B  (Desai et al., 2014; Taff et al., 2013; Vediyappan et al., 2010; Zarnowski et 99 
al., 2014).  100 
 In this context, researchers have sought alternative antifungal targets and/or ways to 101 
improve the fungicidal effect of existing AFs. Such approaches notably involve targeting 102 
chaperones such as Hsp90 or components of stress signaling pathways, since these targets are 103 
more likely to simultaneously affect resistance to different classes of AF, morphogenesis 104 
mechanisms, cellular fitness and adaptation to changing environments. Key studies have been 105 
conducted in these areas by, for example, Brown and colleagues (Brown et al., 2010) and 106 
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Cowen and coworkers (Singh et al., 2009). Works of this latter group established the complex 107 
connections between Pkc1, Hsp90 and calcineurin suggesting interesting new strategies to 108 
treat fungal infections (LaFayette et al., 2010). However, these cellular targets suffer from a 109 
major drawback in that they are conserved in mammalian host cells, which make achieving 110 
fungal specificity a real challenge. Factors that regulate the pathogen’s cell wall therefore 111 
remain a strong target for new, fungus-specific, therapeutic approaches. 112 
 Here we describe the role of Smi1, a C. albicans protein homologous to the 113 
Saccharomyces cerevisiae hub protein Knr4 which interacts physically with both the Slt2 114 
MAP kinase and calcineurin, thus connecting the two primary signaling pathways involved in 115 
cell wall maintenance during stress: the cell wall integrity pathway (CWI) and the calcineurin 116 
pathway (Dagkessamanskaia et al., 2010; Martin-Yken et al., 2016). Knr4 is required for 117 
resistance to cell wall stress induced by elevated temperature or the presence of antifungal 118 
compounds, including Caspofungin (Lesage et al., 2004; Markovich et al., 2004). Knr4 also 119 
plays a role in filamentous and pseudohyphal growth, mucin secretion and agar invasion 120 
(Birkaya et al., 2009). Similarly, GS1 protein, the homolog of Knr4 and Smi1 in the model 121 
filamentous fungi Neurospora crassa, is also involved in the control of morphogenesis, 122 
Caspofungin sensitivity and new cell wall synthesis notably -glucans (Enderlin and 123 
Selitrennikoff, 1994; Resheat-Eini et al., 2008; Seiler and Plamann, 2003). 124 
 The Candida albicans genome encodes 2 homologs of KNR4: SMI1 and SMI1B. 125 
Previous studies have shown that deletion of SMI1 affects cell wall -glucan synthesis, 126 
biofilm formation and biofilm extracellular matrix production, as well as  biofilm-associated 127 
resistance to Fluconazole (Nett et al., 2011). Global transcriptomic studies indicate that SMI1 128 
expression is induced in hyphal and planktonic cells by Cyr1 and is also biofilm-induced, 129 
while it is repressed by the Hap43 regulatory protein and Caspofungin (Liu et al., 2005). 130 
Much less is known about SMI1B, although it appears to be the closest homolog of S. 131 
cerevisiae KNR4 according to phylogeny.  132 
 In this paper we further characterize the function of SMI1 in C. albicans. We provide 133 
evidence that Smi1 is a functional homolog of S. cerevisiae protein Knr4, that its accurate 134 
expression is critical for the regulation of fungal cell wall integrity and biophysical properties, 135 
and that the cellular localization of Smi1-GFP in yeast and hyphal cells is consistent with the 136 
ones observed for its counterparts, i.e. Knr4 in S. cerevisiae yeasts and GS1 in the hyphae of 137 
N. crassa. 138 
 139 
  140 
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Material and Methods  141 
Strains and growth media 142 
 143 
The C. albicans and S. cerevisae strains used in this study are listed in Table 1.  144 
Depending on experimental conditions, yeast strains were grown in YPD (1 % (W/V) yeast 145 
extract, 2 % (W/V) peptone, and 1 % (W/V) dextrose), YP (1 % (W/V) yeast extract, 2 % 146 
(W/V) peptone) supplemented with 10 % Fetal Bovine Serum (FBS), or SD (synthetic 147 
dextrose, 0.67 % (W/V) yeast nitrogen base (YNB; Difco) with 2 % glucose) supplemented as 148 
necessary with arginine, histidine or uridine (20 mg/l). Agar (2 %) was used for growth on 149 
solid medium. Escherichia coli strains TOP10 (Invitrogen) or DH5α were used for DNA 150 
cloning and maintenance of the plasmid constructs.  151 
 152 
Plasmid construction and generation of epitope-tagged or mutant strains: 153 
C. albicans SM1 gene was PCR amplified with primers: Sense SMI1 New start and  154 
Antisense SMI1 (sequences in Supplementary Material Table S1). The PCR product was then 155 
cloned in the S. cerevisae expression vector  YEplac195 PGK/CYC1 between PGK promotor 156 
PPGK1 and CYC1 terminator sequences (personal gift of Dr J.L. Parrou, based on YEplac195 157 
(Gietz and Sugino, 1988)), thus yealding pSM1 plasmid. Plasmid pKNR4 expressing the S. 158 
cerevisae KNR4 gene with its own promotor and terminator on a multicopy vector has been 159 
described previously (Martin et al., 1999). 160 
S. cerevisiae cells were transformed according to the lithium acetate method (Gietz and 161 
Woods, 2006). C. albicans cells were transformed using the lithium-acetate protocol of 162 
Walther and Wendland (Walther and Wendland, 2003), followed by selection of 163 
transformants for uridine, arginine or histidine prototrophy when using the URA3, ARG4 or 164 
the HIS1 markers, respectively.  165 
Construction of C. albicans smi1  and smi1B  knock-out mutants (Table 1) used PCR-166 
generated ARG4 and HIS1 disruption cassettes flanked by 120 base pairs of target homology 167 
region (primer sequences are provided in supplementary material S1) as described by (Gola et 168 
al., 2003) and (Schaub et al., 2006). Independent transformants were produced and the gene 169 
replacements were verified by PCR on whole yeast cells as described previously (Gola et al., 170 
2003; Schaub et al., 2006). 171 
The SMI1 (C1_07870C_A) gene was amplified using primers: SMI1 Forward and SMI1 172 
Reverse (sequences provided in supplementary material Table S1). The resulting 1.6Kb PCR 173 
product was purified and inserted in the GTW sequences of pEntry (Gateway system
TM
, 174 
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Invitrogen). Construction of the Smi1 over-expressing strain was performed by recombination 175 
of pEntry-SMI1 plasmid and pCIp10-PTDH3-GTW plasmid  (Chauvel et al., 2012) also using 176 
the Gateway system
TM
 (Invitrogen), followed by genome integration through targeted 177 
homologous recombination at the genomic RPS10 locus in the host strain BWP17.  178 
 179 
GFP tagging of Smi1 180 
Smi1 was C-terminally-tagged with GFP by amplifying GFP-NAT cassette from the pGFP-181 
NAT1 plasmid (Milne et al., 2011) using primers gSmi1 _F
a
 and gSmi1_R
a
 containing 100 bp 182 
of flanking homology to the SMI1 terminator and C-terminal of the SMI1 ORF 183 
(C1_07870C_A), respectively (Figure X –primer table). Transformants were selected on YPD 184 
agar containing 300 µg/ml nourseothricin (Sigma). Integration of the GFP-NAT cassette was 185 
confirmed by PCR using primers sSmi1_F and sFP_R, which anneal to the chromosome 186 
outside the targeted region and within the cassette, respectively (primer sequences are 187 
provided in Supplementary material Table S1).  188 
 189 
Microscopy of Smi1-GFP 190 
Yeast were grown for 2 h at 30 °C in YNB medium containing amino acids and (NH4)2SO4 191 
(Sigma Aldrich).  Morphogenesis was induced at 37 °C for 3 h in 20 % FCS, 2 % glucose.  192 
Cells were imaged on µ-slides (Ibidi, Martinsried, Germany). Images of Smi1-GFP 193 
localization were captured on an UltraVIEW® VoX spinning disk confocal microscope 194 
(Nikon, Surrey, UK), using a 488 nm laser. Multiple Z-stack images were acquired and Z-195 
stack projections at maximum intensity were created using Volocity 6.3 software (Perkin 196 
Elmer). 197 
 198 
Phenotypic Sensitivity tests: 199 
Drop tests to evaluate the sensitivity of different strains and mutants to cell wall affecting 200 
drugs were performed as previously described (Ram et al., 1998) with minor modifications 201 
(Martin et al., 1999).  Briefly, yeast cells were grown in liquid YPD to OD600 of 1+/- 0.1, then 202 
concentrated by centrifugation and resuspended in sterile water to an OD600 of 8. Serial 203 
dilutions of 1/1, 1/10, 1/100 and 1/1000 were then spotted on solid media containing either 204 
calcofluor white or Caspofungin at the indicated concentrations. Growth was scored and 205 
photographs taken after 48h of incubation at 30 °C, or at 37 °C for testing the sensitivity to 206 
elevated temperature. 207 
 208 
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Atomic Force Microscopy:   209 
 210 
Sample preparation for AFM experiments.  211 
Yeast cells were concentrated by centrifugation, washed two times in acetate buffer (18 mM 212 
CH3COONa, 1mMCaCl2, 1mMMnCl2, pH5.2), resuspended in the same buffer, and 213 
immobilized on polydimethylsiloxane (PDMS) stamps prepared as described by Dague et al. 214 
(Dague et al., 2011; Formosa et al., 2014a). Briefly, freshly oxygen-activated microstructured 215 
PDMS stamps were covered with a total of 100 l of cell suspension and allowed to stand for 216 
15 min at room temperature. Yeast cells were then deposited into the stamps microstructures 217 
by convective (capillary) assembly.  218 
Force curves were then recorded in acetate buffer in quantitative-imaging mode (JPK 219 
Instruments, 2011, QITM mode-quantitative imaging with Nano-Wizard 3 AFM),(Chopinet et 220 
al., 2013; Formosa et al., 2014b; Smolyakov et al., 2016) with MLCT AUWH cantilevers 221 
(nominal spring constants: 0.01, 0.1, and 0.5 N/m). For imaging, cantilevers with a spring 222 
constant of 0.01 N/m were used. For force spectroscopy experiments, cantilevers with spring 223 
constants of 0.1 and 0.5 N/m were used. The applied force was kept at 1 nN for both imaging 224 
and force spectroscopy. For imaging and force spectroscopy, we used an AFM Nanowizard 225 
III (JPK Instruments, Berlin, Germany). The spring constant of each cantilever was 226 
determined by the thermal-noise method (Hutter and Bechhoefer, 1993).  227 
For elasticity measurements, force maps of 32 by 32 or 64 by 64, hence either 1024 or 4096 228 
force curves were recorded on a 1 m x 1 m square area on top of the cells. The force-229 
distance curves recorded were transformed into force-indentation curves by subtracting the 230 
cantilever deflection on a solid surface. The indentation curves were then fitted to the Hertz 231 
model (Hertz, H., 1881). 232 
 233 
 234 
Fluorescence Microscopy: 235 
 236 
Yeast were grown for 2 h at 30 °C in YNB medium containing amino acids and (NH4)2SO4 237 
(Sigma Aldrich).  Morphogenesis was induced at 37 °C for 3 h in 20 % FCS, 2 % glucose.  238 
Cells were imaged on µ-slides (Ibidi, Martinsried, Germany). Images of Smi1-GFP 239 
localization were captured on an UltraVIEW® VoX spinning disk confocal microscope 240 
(Nikon, Surrey, UK), using a 488 nm laser. Multiple Z-stack images were acquired and Z-241 
stack projections at maximum intensity were created using Volocity 6.3 software (Perkin 242 
Elmer). 243 
  244 
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Results: 245 
   246 
1. Conservation of cellular function between Saccharomyces cerevisiae Knr4 and Candida 247 
albicans Smi1: 248 
  The genome of the human pathogen Candida albicans contains two distinct homologs 249 
of the Saccharomyces cerevisiae KNR4 gene, SMI1 (C1_07870C_A) and SMI1B 250 
(C3_05350C_A).  Gene deletion mutants for each gene were generated and initial phenotypic 251 
analysis showed a strong phenotype (sensitivity to CFW or SDS) for the smi1 mutant but 252 
not for the smi1B mutant (Figure S1).  We therefore focused on the role of Smi1 in this 253 
study.   254 
 The SMI1 open reading frame was amplified and cloned into a S. cerevisiae expression 255 
vector, under the control of the strong and constitutive ADH1 promoter. The SMI1 coding 256 
sequence is 1,863 bp and contains two GTC codons at positions 1717 and 1762, which have a 257 
97 % chance of translation as a Serine in C. albicans through non-canonical codon usage in 258 
this fungus, compared to a Leucine in S. cerevisiae (White et al., 1995), although these usage 259 
frequencies appear to be sensitive to environmental stressors (Simões et al., 2016). These two 260 
codons are located within the C-terminal of Smi1, which is less conserved than the central 261 
domains among members of the fungal Knr4/Smi1 super-family of proteins. The complete 262 
sequence alignment of several fungal protein members of this super-family is shown in Figure 263 
S2. The C-terminal part of Knr4 is largely unstructured and not directly necessary for protein 264 
function in S. cerevisiae (Dagkessamanskaia et al., 2010; Martin-Yken et al., 2016). Hence, 265 
we tested the ability of the C. albicans SMI1 gene, retaining its two ambiguous codons, to 266 
complement the cell wall-related phenotypes of S. cerevisiae knr4 null mutants. Our 267 
phenotypic screen included sensitivity to Calcofluor White (CFW), SDS, caspofungin and 268 
elevated temperature in haploid and diploid S. cerevisiae genetic backgrounds. CFW is a 269 
compound that binds to nascent chitin fibrils and has been used since 1994 to identify fungal 270 
cell wall mutants (Ram et al., 1994).  Expression of SMI1 gene in S. cerevisiae was able to 271 
complement these phenotypes (Figure 1A) and also complemented the smi1Δ growth defect at 272 
elevated temperature (Fig.1B), a specific defect in this organism that is linked to cell cycle 273 
progression through START (Fishel et al., 1993, Martin-Yken et al., 2003). Hence, the 274 
function of the Smi1/Knr4 proteins appears to be conserved between the two species despite 275 
their phylogenetic distance and the differences between the two protein sequences, which 276 
share only 34% identity and 49% similarity (Figure S1).  277 
 278 
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 279 
2. Deletion of SMI1 renders C. albicans sensitive to cell wall targeting drugs:   280 
 281 
 We further investigated the role of Smi1 in maintaining cell wall integrity using a 282 
medically relevant β-glucan synthase-targeting drug, the echinocandin Caspofungin. The 283 
influence of Smi1 on the sensitivity to CFW was also retested in parallel. Homozygous 284 
deletions of the two alleles of SMI1 gene in the C. albicans BWP17 genetic background lead 285 
to a marked increase in the sensitivity towards both Caspofungin and CFW at 30 °C (Figure 286 
2). These phenotypes are consistent with the ones observed for the S. cerevisiae knr4 mutant 287 
as well as with the role proposed for these proteins in stress signaling pathways (See 288 
discussion). Re-integration of SMI1 open reading frame under the constitutive promoter PTDH3 289 
in the smi1 deletion mutant restored the wild-type phenotype, while integration of the 290 
empty URA3-bearing vector did not (Fig. 2).   291 
 292 
 293 
3. Cell Wall Biophysics  294 
 295 
3.1 Cell Wall Strength / Elasticity  296 
 297 
Atomic Force Microscopy under liquid conditions can be used to investigate the 298 
nanomechnical properties of live wildtype and mutant  cells (Dague et al., 2010; Ene et al., 299 
2015; Formosa et al., 2013; Liu et al., 2015). Here we first measured the cell surface 300 
resistance vs the elasticity of three C. albicans strains: the control strain, BWP17 AHU (which 301 
carries the functional URA3 marker), the homozygous deletion mutant smi1 AHU and a 302 
strain over-expressing the SMI1 gene from the strong constitutive promoter PTDH3 in the same 303 
BWP17 genetic background, SMI1-OE. Using the Atomic Force Microscope in the Force 304 
Volume mode, we collected between 1024 and 4160 force curves per cell on a minimum of 305 
12 cells from 4 independent cultures for each strain. The elasticity of the cells was quantified 306 
from these curves by calculating the Young’s Modulus (YM) as previously described (Dague 307 
et al., 2010), with YM=1 / Elasticity.  The higher the Young’s Modulus, the stiffer the cells 308 
are. As can be seen on Figure 3, the Young’s Moduli measured for the control strain BWP17 309 
AHU showed a mean value of 782 +/-158 kPa, significantly higher than the ones measured 310 
for the homozygous deletion mutant which had a mean value of  93 +/-34 kPa. The Young’s 311 
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Moduli measured on the cells of the over-expression strain lay between the control strain and 312 
the deletion mutant, with a mean of 298 +/- 62 kPa, suggesting either a gene dosage effect for 313 
SMI1 expression or possibly an effect of uncoupling the expression of this gene from the cell 314 
cycle. These values are represented for each cell individually on Figure 3 since to allow 315 
visualization of the cell-to-cell variability. The mean values ± SEM of the Young Moduli 316 
obtained for these three strains are also reported in Table 2. These measurements show that 317 
the deletion of both alleles of SMI1 resulted in a reduction of the cell surface stiffness by eight 318 
to ten fold, indicating a very soft cell wall for this mutant.  319 
 320 
 321 
3.2 Adhesion:  322 
 Another cell surface feature that can be easily and very precisely measured by AFM is 323 
the ability to adhere to surfaces, using Single Molecule Force Spectroscopy (Axner et al., 324 
2010; Benoit et al., 2000; Formosa et al., 2014a; Hinterdorfer et al., 1996; Neuman and Nagy, 325 
2008). Here, adhesion between the cell surface and the AFM bare tips, constituted of Si3N4 326 
was measured by scanning square areas on the top of yeast cells. We recorded force curves 327 
whose retract parts were then used to generate adhesion maps where the intensity of each 328 
pixel corresponds to the force required to dissociate the AFM tip from the sample, i.e. the 329 
adhesion force, expressed in picoNewtons pN (see Figure 4). It can be seen immediately from 330 
these heat maps that the smi1 mutant cell surface is almost not adhesive compared to the 331 
control strain, while the SMI1 overexpressing cells on the other hand display a marked 332 
increase in their surface adhesion. In addition to the visual representation by these adhesion 333 
maps, the cellular adhesion was also evaluated by three quantitative parameters: the mean 334 
adhesion force and specific energy of each adhesion event observed and the overall 335 
proportion of these adhesive events among all the recorded force curves. In order to quantify 336 
these values we defined as an adhesive event any force curve showing an adhesion force 337 
above 50pN. With this threshold level we calculated the percentage of adhesive events for 338 
each cell type and measured the area situated below the retract curves, which represent the 339 
adhesion energy of the event (Table 2). These values indicated that adhesive events were 340 
encountered more frequently at the surface of the over-expressing strain SMI1-OE (63% of 341 
the recorded 21,500 force curves) than on the control strain (46% of over 13,300 force 342 
curves), and were rare on the deletion mutant surface (19% of over 12,300 force curves). The 343 
average adhesion force measured on the control strain was of 127 +/- 52 pN, calculated on 344 
6256 adhesive force curves. This has to be compared with an average force of 70 +/-16 pN 345 
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(hence barely above the threshold) on 2300 force curves for the smi1 mutant. For the 346 
SMI1 OE-strain on the other hand, not only were the  adhesive events more frequent (63 %) 347 
but they were also much stronger, with forces measured up to 2176 pN and an average value 348 
of 712 +/- 260 pN calculated on 12,257 adhesive force curves. The specific energy of these 349 
adhesive events also differed; with adhesion energies measured for the over-expressing strain 350 
an order of magnitude stronger that for the control strain, while they were about seven times 351 
lower on the surface of the deletion mutant. Hence, the homozygous deletion of SMI1 gene 352 
abrogates almost entirely the ability of the mutant cell to adhere using the chemistry described 353 
here, while SMI1 over-expression (or constitutive expression) leads to a highly adhesive 354 
phenotype.  355 
 356 
 357 
 358 
4. Cellular Localization:  359 
 360 
The homolog of Smi1 and Knr4 in the model filamentous fungus Neurospora crassa, GS-1 361 
localizes at the growing tip of hyphae as a sphere positioned at the “Spitzenkörper” (Verdin et 362 
al., 2009). The Spitzenkörper (or apical body) is a fungal structure specific to true hyphae, 363 
located at the hyphal tip. It is comprised of the secretory vesicles that are required for 364 
continuous polarized growth (Girbardt, 1957; Harris et al., 2005). GS-1-GFP and Knr4-GFP 365 
have been imaged respectively at the tip of N. crassa hyphae (Riquelme et al., 2011; Sánchez-366 
León et al., 2011) and at the tip of elongated shmoos in S. cerevisiae ((Martin-Yken, 2012) 367 
and our own unpublished data). To test whether the C. albicans homolog would be similarly 368 
positioned, a GFP-tag was integrated at the C-terminus of the Smi1 protein at its 369 
chromosomal locus and its cellular localization was visualized by confocal fluorescent 370 
microscopy in yeast and hyphal cells. 371 
In yeast cells, Smi1-GFP appeared both as punctate patches in the cytoplasm and localized 372 
transiently to nascent buds. This localization is similar to that reported for Knr4 373 
(Dagkessamanskaia et al., 2010; Martin et al., 1999). Punctate patches and a more diffuse 374 
cytoplasmic distribution were observed in C. albicans hyphae, but, unlike in yeast, Smi1-GFP 375 
was consistently retained at the growing hyphal tip throughout the cell cycle.  This is 376 
reminiscent of N. crassa GS-1 localization (see above and discussion). Smi1-GFP was 377 
occasionally observed at hyphal septa as a dim signal, but this presence did not reflect specific 378 
stages of the cell cycle.  Hence, Smi1 in C. albicans appears to associate with intracellular 379 
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organelles and localizes to sites of new cell wall growth, a pattern which partially reflects 380 
those observed for homologs of Smi1 in S. cerevisae in yeast cells and the hyphae of N. 381 
crassa.  382 
 383 
 384 
  385 
DISCUSSION  386 
 387 
 Our results establish a significant conservation of Knr4/Smi1 function between S. 388 
cerevisiae and C. albicans and demonstrate the role of Smi1 in resistance to Caspofungin, 389 
regulation of cell wall integrity and cell surface adhesion properties of this major human 390 
fungal pathogen. These features suggest that Smi1 might be relevant as a new drug target for 391 
combination therapies. Previous work by Nett and colleagues identified a role for Smi1 in the 392 
production of extracellular matrix upon biofilm formation and hence the associated resistance 393 
to Fluconazole (Nett et al., 2011). Their results indicated that these effects were linked to the 394 
cell wall integrity pathway but were in fact regulated by Smi1 independently of the CWI 395 
pathway, suggesting a control pathway for Smi1 distinct from that of the PKC pathway. 396 
Lafayette and colleagues dissected the mechanisms through which PKC regulates resistance 397 
to both azoles and echinocandins in the two yeast models C. albicans and S. cerevisiae 398 
(LaFayette et al., 2010). They showed that, in C. albicans, Pkc1 and calcineurin signaling 399 
pathways independently regulate antifungal resistance via a common unknown target, which 400 
they designed as “X” (see (LaFayette et al., 2010), Fig 9B thereof). Considering the 401 
knowledge accumulated on Knr4 in budding yeast together with the data obtained for C. 402 
albicans and presented here, we propose that Smi1 might constitute this previously 403 
unidentified “X”, a common target of the Pkc1 and calcineurin signaling pathways. In 404 
addition, another result of this work is the very low stiffness of the smi1 mutant cell wall 405 
indicated by its Young Modulus (Fig. 3, Table 2)The severity of this phenotype compared to 406 
the milder one observed for S. cerevisiae knr4 mutant suggests a more important (central) 407 
role of Smi1 in the network of signaling pathways controlling cell wall integrity than that of 408 
Knr4 in the baker yeast, which is in agreement with these two proteins being the hypothetical 409 
“X” in the work of LaFayette and colleagues (LaFayette et al., 2010). The very soft cell wall 410 
phenotype observed for the deletion mutant smi1 is similar to, although more severe, than 411 
the one observed for the S. cerevisiae knr4 mutant whose Young’s Modulus in stationary 412 
phase was reduced three-fold compared to the control strain (Dague et al., 2010). This could 413 
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result from the reduced level of -glucan in the cell wall of this mutant previously reported 414 
(Nett et al., 2011). The fact that the homozygous deletion mutant smi1 is so strongly 415 
affected, despite the presence in this strain of both functional alleles of SMIB, argues for a 416 
major role for the SMI1 gene, at least in the conditions tested (30°C, liquid rich medium, yeast 417 
form of C. albicans cells). 418 
 419 
 Our results show that homozygous deletion of SMI1 gene leads to a marked increase in 420 
the sensitivity of C. albicans to both CFW and Caspofungin at 30 °C. Since Caspofungin 421 
tolerance has been reported in C. albicans mutants with elevated cell-wall chitin  (Perlin, 422 
2015; Plaine et al., 2008; Walker et al., 2013; Yang et al., 2017) while elevated chitin is 423 
known to induce hypersensitivity to CFW (Elorza et al., 1983; Roncero and Durán, 1985), this 424 
finding may appear puzzling at first glance. However, this is consistent with the phenotypes 425 
observed for the S. cerevisiae knr4 mutant (Lesage et al., 2004; Martin et al., 1999). 426 
Moreover, as our cell wall stiffness measurements, these phenotypes indicate a severely 427 
modified cell wall organization of the deletion mutant smi1 compared to the control strain, 428 
coherent with a possible upstream role of Smi1 in cellular signaling pathways allowing this 429 
protein to influence simultaneously the expression level of different cell wall synthesis genes. 430 
Consistent with this, early results obtained in the bakers’ yeast established a role for Knr4 in 431 
the transcriptional control of all S. cerevisiae chitin synthase genes (Martin et al., 1999). The 432 
complex interplay of cellular signaling pathways controlling C. albicans susceptibility to 433 
echinocandins has been described by Munro and colleagues (Walker et al., 2010), and it now 434 
seems possible that Smi1 is one piece of this puzzle.   435 
 A previous study investigating the effects of Caspofungin on the yeast cell wall by 436 
Atomic Force Microscopy did reveal that treatment by this echinocandin increased C. 437 
albicans cell wall stiffness and at the same time enhanced cell surface adhesion (Formosa et 438 
al., 2013). With this in mind, together with the remarkable sensitivity of the smi1deletion 439 
mutant to this drug, it is tempting to postulate that SMI1 gene product is required for the 440 
establishment of the cell’s response to Caspofungin. It has however not been possible to test 441 
the effect of Caspofungin treatment on the deletion mutant by AFM, precisely due to its 442 
extreme sensitivity and lethality in the conditions of the test. 443 
 The cellular localization observed for Smi1 in yeast cells and hyphae, as cytoplasmic 444 
patches and concentrated spots at the polarized growth sites, is coherent with the idea of 445 
cellular function conservation between Smi1 and S. cerevisiae Knr4. Indeed, similar cellular 446 
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localization has been reported for the MAP kinase Slt2 and for Calmodulin, the phosphatase 447 
which activates Calcineurin (Brockerhoff and Davis, 1992; van Drogen and Peter, 2002). In 448 
the model filamentous fungus, N. crassa, GS1, the homolog of Smi1, localizes at the 449 
Spitzenkörper within the hyphal tip (Verdin et al., 2009; Sánchez-León et al., 2011). This 450 
localization is conserved in another ascomycete filamentous fungus, A. nidulans (also called 451 
Emericella nidulans), (Schultzhaus et al., 2015). The results presented here indicate that Smi1 452 
also localizes in or around the Spitzenkörper of C. albicans hyphae in a similar manner to that 453 
observed for GS-1 in N. crassa. Finally, given the cell wall related phenotypes reported for 454 
GS-1 mutants of N. crassa (Enderlin and Selitrennikoff, 1994; Resheat-Eini et al., 2008; 455 
Seiler and Plamann, 2003), it is tempting to speculate that the function of these proteins is not 456 
only conserved between C. albicans and S. cerevisiae, but also, to some extent at least, in 457 
filamentous fungi. The role of Smi1 in the control of cell wall synthesis, cellular adhesion and 458 
drug resistance is of great interest with regard to finding new antifungal targets. The decisive 459 
advantage of Smi1 as a drug target over Hsp90, calcineurin, Pkc1 or other MAP kinases is the 460 
fact that the Knr4/Smi1 superfamily of proteins is specific of the Fungal Kingdom and absent 461 
from host cells (Martin-Yken et al., 2016). In addition, since this protein family is conserved 462 
among fungi, including other fungal pathogens of mammals (C. glabrata and Aspergillus 463 
species notably) and also plants (ex: Magnaporthe grisea), developing drugs that target Smi1 464 
might lead to broader antifungal applications in domains such as agriculture. 465 
 466 
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 482 
Strain name Genotype References 
Candida albicans strains : 
BWP17 ura3∆::λimm434/ura3∆::λimm434, arg4∆::hisG/arg4∆::hisG, 
his1∆::hisG/his1∆::hisG 
(Wilson et al., 1999)  
CEC161 Isogenic to BWP17 but arg4∆::hisG/ARG4, his1∆::hisG/HIS1  (Firon et al., 2007)  
BWP17 AHU Isogenic to CEC161 but  RPS1/rps1::CIp10-URA3 (Chauvel et al., 2012) 
smi1 Isogenic to BWP17 but smi1∆::HIS1/smi1∆::ARG4 This study 
smi1- AHU Isogenic to smi1∆/∆ but RPS1/rps1::CIp10-URA3 This study 
smi1PTDH3 
SMI1 
Isogenic to smi1∆/∆ but RPS1/rps1::CIp10-PTDH3-SMI1 This study 
smi1B Isogenic to BWP17 but smi1B∆::HIS1/smi1B∆::ARG4 This study 
SMI1-OE Isogenic to CEC2908 but RPS1/rps1::CIp10-PTDH3-SMI1 This study 
DAY185 ura3::imm434/ura3::imm434 his1::hisG::HIS1/his1::hisG 
arg4::hisG::ARG4-URA3/arg4::hisG 
Davis et al., 2000 
SMI1-GFP  DAY185 SMI1::SMI1-GFP-NAT This study 
Saccharomyces cerevisiae strains : 
BY4741a MAT a; his3∆1 leu2∆0; met15∆0; ura3∆0 (Brachmann et al., 
1998) 
knr4  BY4741a YGR229c::KanMX4 YKO Collection 
(Open Biosystems) 
W303-2N MAT a/ ura3-1/ura3-1 leu2-3,112/leu2-3,112 trp1- 
1/trp1-1 his3-11,15/his3-11,15 ade2-1/ade2-1 can1- 
100/can1-100 
 
HM1315 W303-2N YGR229c::KanMX4/ YGR229c::KanMX4 This study. 
 483 
Table 1. Yeast strains used in this study. 484 
 485 
 486 
 487 
 488 
Cell Type 
Young Modulus 
(kPa) 
% of Adhesive 
events 
 
Mean Adhesion 
Force (pN) 
Adhesion Energy  
(=Area below the 
force curve) (J) 
16 
 
BWP17 AHU 782 (+/- 158)  46.1 
 
127 (+/- 52) 1.77 x10
-17
 
smi1 AHU 93 (+/- 34) 19.4 
 
70 (+/- 26) 0.26 x10
-17
 
SMI1-OE 298 (+/- 62) 62.9 
 
712 (+/- 445) 15.82 x10
-17
 
 489 
 490 
Table 2: Summary of Atomic Force Microscopy measurements for BWP17 AHU, 491 
smi1 AHU, and SMI1-OE strains. 492 
 493 
Column 1: Mean values with standard deviation of Young’s Moduli calculated from force 494 
curves obtained as described above (3.1).  495 
Column 2: Percentage of adhesive events measured by AFM, calculated from at least 12,000 496 
force curves for each cell type, with a threshold level for the definition of an adhesive event as 497 
50pN on the retraction curve.  498 
Column 3: Mean values of Adhesion forces for each cell type, calculated from adhesive force 499 
curves obtained as described above. 500 
Column 4: Mean values of the Adhesion Energy for each strain, calculated from the area 501 
below the force curves presenting an adhesion event.  502 
 503 
 504 
  505 
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LEGENDS TO FIGURES 506 
 507 
Figure 1. C. albicans SMI1 gene expression suppresses the cell wall associated 508 
phenotypes of S. cerevisiae knr4  mutants.  509 
A) Transformed control strain BY4741a and mutant strain knr4 with either empty plasmid 510 
YEplac195 PGK/CYC1 or pSM1 bearing C. albicans SM1 gene or pKNR4 bearing S. 511 
cerevisiae KNR4 gene were grown  in liquid SD medium lacking uracile at 30°C to an OD600 512 
of 1, and concentrated to OD600 8±0. Serial dilutions of yeast cultures were spotted on YPD 513 
plates in the absence or presence of 150 ng caspofungin ml−1. Growth was scored after 2 514 
days at 30°C. 515 
B) Transformed control strain W3032N and mutant strain HM1315 knr4  with either 516 
empty YEplac195 PGK/CYC1 plasmid or pSM1 (Yeplac195 bearing C. albicans SM1 gene 517 
under PPGK1) or pKNR4 (Yeplac195 bearing S. cerevisiae KNR4 gene under PPGK1) were 518 
grown overnight in liquid SD medium lacking uracile at 30°C and concentrated to OD600 8±0. 519 
Serial dilutions of yeast cultures were spotted on YPD plates. Growth was scored after 2 days 520 
at 30°C and 37°C. 521 
 522 
Figure 2. Calcofluor White and caspofungin sensitivity of the C. albicans smi1 523 
mutant.  524 
Control strain BWP17 and mutant strain smi1  were grown in liquid YPD medium at 30°C 525 
to an OD600 of 1, and concentrated to OD600 8±0. Serial dilutions of yeast cultures were 526 
spotted on YPD plates in the absence or presence of 40mg of CFW or 150 ng caspofungin 527 
ml−1. Growth was scored after 2 days at 30°C. 528 
 529 
 530 
Figure 3. Young Moduli of smi1 mutant and SMI1-OE vs control strain. 531 
Atomic Force Microscope was used to collect over 12,300 force curves for each strain on the 532 
control strain BWP17 AHU, the smi1 mutant AHU and the SMI1-OE strain over-533 
expressing the SMI1. The Young’s Moduli (YM =1 / Elasticity) were quantified from these 534 
curves as described and are presented here as a dot on the mean YM value, with SEM for 535 
each cell. The bar represents the mean of the YM values with each SEM. Statistical analysis 536 
was done using the One-way ANOVA test, **** = p value < 0.0001. 537 
 538 
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 539 
Figure 4. Adhesion Maps recorded on the cellular surfaces of smi  mutant and SMI1-540 
OE vs control strain.   541 
Adhesion force measurements performed on single C. albicans cells by Atomic Force 542 
Microscopy. The adhesion maps presented have been recorded on three independent and 543 
representative C. albicans cells for each cell type. Each analyzed area covers 1×1 µm2.  544 
Adhesion scales are shown and read as follows: bright yellow = maximum adhesion force at 2 545 
nN; dark red = minimum at 0.0 nN.  546 
 547 
Figure 5. Smi1-GFP localizes to apical growth sites in yeast and hyphae. Cells were 548 
grown on Ibidi µ-slides in YNB medium at 30°C for 2h (yeast) and 20 % FCS, 2 % glucose at 549 
37°C for 3h (hyphae). Smi1-GFP localised transiently to emerging bud tips in yeast (arrows) 550 
and to septa in hyphae (asterisks) but was maintained consistently at hyphal/branch tips 551 
(arrows). Punctate fluorescence patches were also observed throughout yeast and hyphal cells. 552 
Images are maximum projections of individual z-stacks. 553 
 554 
 555 
 556 
  557 
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